MxBiodevices LLC
Injectable wound repair scaffold for diabetic foot ulcers
This article was originally published in Start Up
Executive Summary
Despite the proliferation of advanced wound care products to treat diabetic foot ulcers, ranging from negative-pressure wound therapy to moist wound dressings and antimicrobials to artificial skin and growth factors, there has been minimal impact on clinical outcomes, according to MxBiodevices LLC. The start-up has already completed two human clinical trials of its injectable wound repair scaffold that is injected just under the wound surface to provide a healing structure.
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.